Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Pediatrics
100%
Infliximab
87%
Crohn's Disease
85%
Pediatrics Patient
69%
Patient with Crohn's Disease
52%
Ulcerative Colitis
35%
Azathioprine
25%
Biological Product
18%
Inflammatory Bowel Disease
18%
Diseases
17%
Upper Digestive Tract
15%
TNF Inhibitor
14%
Therapeutic Drug Monitoring
14%
Faecal Calprotectin
14%
Adalimumab
13%
Biological Marker
13%
Intestine Lymphangiectasia
13%
Combination Therapy
11%
Nonalcoholic Fatty Liver
11%
Lymph Duct
10%
Vedolizumab
9%
Adolescence
9%
Embolization
8%
Long-Term Outcome
8%
Corticosteroid
8%
Maintenance Therapy
8%
Steroid
8%
Monotherapy
7%
Disease Course
7%
Secondary Loss
7%
Patient with Ulcerative Colitis
7%
Trough Level
7%
Liver Transplantation
7%
Endoscopy
6%
Magnetic Resonance Enterography
6%
Pyoderma gangrenosum
6%
Cohort Analysis
6%
COVID-19
6%
Portosystemic Anastomosis
6%
Biological Therapy
6%
Glucose Intolerance
6%
Primary Immunodeficiency
6%
Pylorus Stenosis
6%
Awareness
6%
Drug Dose Intensification
6%
Patient with Obesity
6%
Microbiome
6%
Prospective Cohort Study
6%
Enteric Feeding
6%
Chronic Pancreatitis
6%
Pharmacology, Toxicology and Pharmaceutical Science
Crohn's Disease
65%
Infliximab
45%
Therapeutic Drug Monitoring
20%
Remission
19%
Azathioprine
19%
Adalimumab
14%
Ustekinumab
13%
Biological Product
12%
Trough Level
12%
Combination Therapy
9%
Tumor Necrosis Factor
8%
Monotherapy
7%
Enzyme-Linked Immunosorbent Assay
7%
Tumor Necrosis Factor Inhibitor
7%
Biological Marker
6%
Albumin
6%
Globulin
6%
Pyoderma gangrenosum
6%
Triptorelin
6%
Immunoassay
6%
Autoimmune Hepatitis
6%
Precocious Puberty
6%
Methotrexate
6%
Ulcerative Colitis
6%
Luteinizing Hormone
6%
Thiopurine Methyltransferase
6%
Gonadotropin
6%
Corticosteroid
6%
Nursing and Health Professions
Pediatrics
27%
Infliximab
22%
Remission
21%
Pediatrics Patient
20%
Crohn's Disease
19%
Patient with Crohn's Disease
14%
Biological Product
14%
Corticosteroid
7%
Azathioprine
7%
Therapeutic Drug Monitoring
7%
Maintenance Therapy
7%
Disease Course
7%
Ulcerative Colitis
7%
Immunoassay
6%
Clinical Outcome
6%
Magnetic Resonance Enterography
6%
Autoimmune Hepatitis
6%
Inflammatory Bowel Disease
6%
Patient with Obesity
6%
Vedolizumab
6%
COVID-19
6%
Glucose Intolerance
6%